1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
TXNM Energy and Blackstone Infrastructure extended the merger agreement's termination date to May 31, 2027, and TXNM entered into a $400 million term loan to repay Blackstone-affiliated buyer Troy TopCo LP for a 2025 stock sale that the New Mexico regulator declared void. The merger still needs approvals from the Nuclear Regulatory Commission and the New Mexico Public Regulation Commission, and TXNM plans to repay the loan by issuing common stock, which could dilute existing shareholders.
Merger termination date extended to May 31, 2027; if payable, the Parent Termination Fee is reduced from $350 million to $175 million.
$400 million TXNM 2026 Term Loan with Wells Fargo as administrative agent, maturing January 17, 2029, used solely to repay the $400 million PIPE purchase.
The NMPRC declared the PIPE Transaction void in a final order dated July 2, 2026.
TXNM plans to issue common stock for $400 million gross proceeds at no less than $50.00 per share to repay the loan; the press release estimates closing in the first half of 2027.
Exodus Movement approved a restructuring plan on July 16, 2026, that will affect about 77 employees and individual service providers, roughly 25% of its global workforce. The company expects $2.5 million to $3.5 million in charges, mostly severance and personnel costs, and projects $10 million to $13 million in annualized cash operating expense savings, with the full benefit in 2027.
Reduction in force affects about 77 employees and non-employee service providers, about 25% of the global workforce.
Expected pre-tax charges of $2.5 million to $3.5 million, mostly severance and related personnel costs, with most cash payments over the next 12 weeks.
Expected annualized cash operating expense savings of $10 million to $13 million, with full benefit in 2027.
Plan expected to be completed in the fourth quarter of 2026; the company says charges may differ materially and additional costs are possible.
Penguin Solutions issued $750.0 million of 0.00% convertible senior notes due August 1, 2031, including a $100.0 million option that the initial purchasers exercised in full. The company is using the estimated $735.1 million in net proceeds to repurchase $295.5 million of existing 2029 and 2030 convertible notes, pay $49.1 million for capped call transactions, and repay $100.0 million under a credit agreement. The new notes are convertible at an initial price of about $116.70 per share, and the capped calls are intended to reduce potential dilution.
$750.0 million principal, 0.00% interest rate, maturing August 1, 2031; initial conversion price of about $116.70 per share
Estimated net proceeds of $735.1 million, including about $136.7 million to repurchase $135.5 million of 2029 notes and about $161.4 million to repurchase $160.0 million of 2030 notes
Capped call cost of about $49.1 million with an initial cap price of $175.05 per share; $100.0 million used to repay the credit agreement
On July 13, 2026, Jet.AI completed the separation and merger that transferred its fractional and jet card business to flyExclusive, in exchange for flyExclusive Class A shares. The filing lists about $9.05 million in closing shares at a $1.595 share price, with a further reserve of shares held until the final purchase price is set. On July 15, Jet.AI also disclosed a non-binding letter of intent for a reverse takeover that it expects would deliver about $20 million in cash and stock to shareholders.
Closing: 5,676,892 flyExclusive shares issued July 13, 2026, valued at about $9,054,642.74 at the $1.595 closing price
Reserve: 1,419,223 shares held in reserve, with the final amount depending on a post-closing purchase price expected within 120 days
Pro forma Q1 2026 revenue was $361,680 versus $1,711,236 historical, and pro forma net loss was $1,391,660 versus $2,681,102 historical
July 15, 2026: non-binding LOI for a reverse takeover with a private company valued at about $300 million; no definitive agreement yet
Alico, Inc. entered into a third amended and restated employment agreement with CEO John Kiernan effective July 14, 2026, extending his term through September 30, 2030. The filing also grants him up to 160,000 performance-based restricted stock units tied to 60-day volume-weighted average price targets from $40 to $110 per share.
Employment term extended through September 30, 2030; base salary of $550,000 in year one, rising to $650,000 by year five
Enhanced severance of 200% of annual base salary, payable over 24 months, if terminated without Cause or for Good Reason after a Change in Control
Discretionary performance bonus of up to $250,000 per year, plus real estate incentive bonuses, at least 75% payable in cash
Up to 160,000 PSUs tied to 60-day VWAP targets of $40 to $110 per share, with time-based vesting through 2030
Actuate Therapeutics received a Nasdaq notice that its Market Value of Listed Securities fell below the $50 million minimum for continued listing on the Nasdaq Global Market from June 1, 2026 to July 14, 2026. The common stock continues to trade under the symbol ACTU, and the company has until January 11, 2027 to regain compliance, which could lead to delisting proceedings if it does not.
Nasdaq notice dated July 15, 2026 cites a market value of listed securities below the $50 million minimum for the period June 1, 2026 to July 14, 2026.
The common stock continues to trade on the Nasdaq Global Market under ACTU, as the notice has no immediate effect on listing.
Compliance Date is January 11, 2027; regaining compliance requires closing at $50 million or more for at least ten consecutive business days.
If compliance is not regained, Nasdaq will issue a delisting notice, which the company may appeal, or the company may consider transfer to the Nasdaq Capital Market.
Lindsay Corporation's Chief Financial Officer, Sam Hinrichsen, plans to resign effective August 31, 2026, citing personal reasons and stating there were no disagreements with the company. The company says the departure is unrelated to its operations, policies, or accounting practices, and it has started a search for a new CFO with an executive recruiting firm.
Sam Hinrichsen resigns as Senior Vice President and Chief Financial Officer effective August 31, 2026
He will provide transition services from the effective date through December 31, 2026, under a written agreement filed as Exhibit 10.1
Transition payments include $100,000 for services and $110,000 tied to outstanding equity awards, plus his 2026 annual bonus under the Management Incentive Plan
The company is paying his COBRA premiums for four months and waived repayment of his cash signing bonus
Csquare sold 50,000,000 shares of common stock at $21.00 per share in its initial public offering, with the sale closing on July 17, 2026 and providing net proceeds of $1,010.0 million. The company also entered agreements with Brookfield that give Brookfield board nomination rights and registration rights for its shares, and it amended its charter and bylaws in connection with the offering.
50,000,000 shares sold at $21.00 per share; underwriters have a 30-day option to buy up to 7,500,000 additional shares
Net proceeds to the company of $1,010.0 million after underwriter discounts and commissions; sale closed July 17, 2026
Stockholders Agreement with Brookfield lets it nominate directors while it owns at least 5% of outstanding common stock
Amended and restated certificate of incorporation and bylaws adopted July 15, 2026
At the July 16, 2026 annual meeting, director nominee Michael D. Magill received 9,173,926 votes for and 9,966,712 against, so he did not win a majority of votes cast. The Board rejected his resignation, which he had tendered under the bylaws, and he will keep his seat, a result that overrides the shareholder vote.
Magill received 9,173,926 for votes and 9,966,712 against votes; the other three nominees were elected.
The Board, with Magill recusing himself, accepted the Nominating and Governance Committee's recommendation and rejected his resignation.
The Board said ISS's recommendation against Magill rested on incorrect information about his independence, and noted he retired from the Company effective December 31, 2021.
Shareholders also approved CohnReznick, LLP as auditor for the fiscal year ending 2027 with 22,260,285 votes for.
Columbia Financial, Inc. said it completed its firm commitment underwritten offering in its second-step conversion, selling 167,236,353 shares at $10.00 per share for total offering proceeds of $1.67 billion. The company also set the final merger consideration for its acquisition of Northfield Bancorp at an aggregate $580 million, with both transactions scheduled to close on July 20, 2026.
167,236,353 shares sold at $10.00 each, for total offering proceeds of $1.67 billion
Existing Holding Company minority shares will be exchanged for 2.2000 shares of Company common stock
Northfield stockholders receive $14.25 in cash or 1.425 shares per share, for aggregate merger consideration of $580 million
Closing scheduled for July 20, 2026; shares expected to trade on Nasdaq as CLBK starting July 21, 2026
South Plains Financial reported second-quarter 2026 net income of $19.0 million, or $0.96 per diluted share, up from $14.5 million and $0.85 in the first quarter and from $14.6 million and $0.86 a year earlier. The results include the Bank of Houston acquisition, completed April 1, 2026, and the company also said CEO Curtis Griffith plans to retire at year-end, with President Cory Newsom expected to lead the company.
Net income was $19.0 million for Q2 2026, versus $14.5 million in Q1 2026 and $14.6 million in Q2 2025.
Diluted EPS was $0.96, versus $0.85 in Q1 2026 and $0.86 in Q2 2025; net interest margin was 4.00%, down from 4.04% in Q1 2026.
The Bank of Houston merger closed effective April 1, 2026, and total deposits reached $4.64 billion at June 30, 2026.
The board declared a quarterly cash dividend of $0.18 per share, payable August 10, 2026 to holders of record on July 27, 2026.
IPG Photonics signed a put option agreement with Lumibird S.A. for the proposed acquisition of 100% of Lumibird Medical, a wholly owned subsidiary of the seller, for €300 million on a cash-free, debt-free basis, plus up to €50 million in contingent earnout tied to 2026 and 2027 performance. The company expects to fund the deal with cash on hand, and closing is expected in the fourth quarter of 2026, subject to a French works council consultation, French foreign direct investment authorization and other customary conditions. Shareholders should note the filing states the deal may not close on the anticipated timeline or at all.
Purchase price of €300 million on a cash-free, debt-free basis, payable in cash at closing, plus up to €50 million contingent earnout based on 2026 and 2027 metrics
Funding from cash on hand; closing expected in the fourth quarter of 2026
Put option becomes binding on IPG only after the seller delivers an exercise notice; if the seller does not exercise by the expiry date, it pays IPG €3.5 million
Lumibird Medical reported fiscal 2025 revenue of €112.2 million and IFRS EBITDA of €24.1 million, per the company's press release
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.